10:22:34 EDT Mon 23 May 2022
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Avivagen Inc (2)
Symbol VIV
Shares Issued 57,223,235
Close 2022-05-11 C$ 0.19
Recent Sedar Documents

Avivagen receives approval for feed additive in China

2022-05-12 09:39 ET - News Release

Mr. Kym Anthony reports

AVIVAGEN ANNOUNCES APPROVAL IN CHINA, THE WORLD'S LARGEST COMMERCIAL FEED PRODUCTION MARKET

Avivagen Inc.'s oxidized carotenoid-based feed additive product has received approval for use in China.

"Core to our success to date has been the strong inroads we've made across key Asian feed markets, and we're thrilled to now have regulatory approval to bring OxC-beta to feed producers and commercial operations across China," said Kym Anthony, chief executive officer of Avivagen. "Having direct access to the world's largest feed market at a time of continued growth has the potential to be transformative for Avivagen and help drive greater adoption and growth in Asia and worldwide."

The approval comes as a result of Avivagen working closely with COFCO Biotech, a state-owned multibillion-dollar company, and follows successful trials across numerous species.

China was ranked as the No. 1 feed-producing country in the world in the 2022 Alltech Agri-Food Outlook, producing 261.4 million metric tonnes in 2021. The country also experienced the largest increase in feed production by tonnage during the year as the country's feed industry continues to consolidate and modernize. The country has been a leader in efforts to reduce antibiotic use with livestock nationwide in an effort to reduce anti-microbial resistance in the region.

About Avivagen Inc.

Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada.

About OxC-beta technology and OxC-beta Livestock

Avivagen's OxC-beta technology is derived from Avivagen discoveries about beta-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours. Through support of immune function, the technology provides a non-antibiotic means of promoting health and growth. OxC-beta Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. The product is currently available for sale in the United States, Philippines, Mexico, Taiwan, New Zealand, Thailand, Brazil, Australia, Vietnam and Malaysia.

Avivagen's OxC-beta Livestock product is safe and effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters. Numerous international livestock trials with poultry and swine using OxC-beta Livestock have proved that the product performs as well as and, sometimes, in some aspects, better than in-feed antibiotics.

We seek Safe Harbor.

© 2022 Canjex Publishing Ltd. All rights reserved.